Cointime

MDxHealth

company

About

MDxHealth is a molecular diagnostics company that develops epigenetic tests for cancer assessment and personalized treatment of patients.

  • 51 - 100

Highlights

Total Funding Amount
€9M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
€9M
Industries
Biotechnology,Health Diagnostics,Medical Device
Founded date
Jan 1, 2003
Number Of Employee
51 - 100
Operating Status
Active

MDxHealth is a molecular diagnostics company that develops and commercializes advanced epigenetic tests for cancer assessment and the personalized treatment of patients.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€9M
MDxHealth has raised a total of €9M in funding over 2 rounds. Their latest funding was raised on Sep 27, 2019 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 27, 2019 Post-IPO Debt €9M 1 Kreos Capital — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
MDxHealth is funded by 1 investors. Kreos Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Kreos Capital Yes Post-IPO Debt
Cointime
เนื้อหา
บริษัท